BNP Paribas Financial Markets’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,790
| Closed | -$64.4K | – | 3502 |
|
|
2020
Q4 | $64.4K | Sell |
2,790
-567
| -17% | -$13.1K | ﹤0.01% | 2786 |
|
|
2020
Q3 | $34.2K | Buy |
3,357
+2,789
| +491% | +$28.4K | ﹤0.01% | 3014 |
|
|
2020
Q2 | $8.46K | Sell |
568
-3,574
| -86% | -$53.3K | ﹤0.01% | 3149 |
|
|
2020
Q1 | $50.5K | Buy |
4,142
+3,279
| +380% | +$40K | ﹤0.01% | 2927 |
|
|
2019
Q4 | $13.7K | Sell |
863
-75
| -8% | -$1.19K | ﹤0.01% | 3419 |
|
|
2019
Q3 | $11.5K | Buy |
+938
| New | +$11.5K | ﹤0.01% | 3481 |
|